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Background: This study sought to explore the relationship between Cystatin C (CysC), a novel cardiovascular (CV) biomarker and anthropometric 
measures of obesity and the influence of this association on mortality (CV, coronary heart disease and all-cause) in a nationally representative 
population free of CV disease, diabetes mellitus and macroalbuminuria (MA) with creatinine-estimated glomerular filtration rate (eGFR) ≥60 ml/
min/1.73m2.
methods: The study cohort included 4,577 adult participants of the Third National Health and Nutrition Examination Survey (NHANES). Spearman’s 
correlation analysis was performed to ascertain the association between various anthropometric measures and CysC. Formal statistical analyses of 
the interaction term between anthropometric measures and CysC for outcomes were performed followed by stratified multivariate Cox proportional 
Hazard analyses.
results: Figures 1 and Table 1
conclusion: CysC correlated better with measures of visceral adiposity (waist circumference and waist height ratio) compared to body mass 
index and appears to be a better predictor of adverse cardiovascular outcomes among those with anthropometric measures in the normal range 
compared to those with abnormal measures of anthropometry.
 
